Luca Gentilucci

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi Cyclopeptide analogs for generating new molecular and 3D diversity
    Luca Gentilucci
    Department of Chemistry G Ciamician, University of Bologna, 40126 Bologna, Italy
    Comb Chem High Throughput Screen 12:929-39. 2009
  2. ncbi Molecular docking of opiates and opioid peptides, a tool for the design of selective agonists and antagonists, and for the investigation of atypical ligand-receptor interactions
    L Gentilucci
    Department of Chemistry G Ciamician, University of Bologna, Via Selmi 2, 40126, Bologna, Italy
    Curr Med Chem 19:1587-601. 2012
  3. ncbi Re-discussion of the importance of ionic interactions in stabilizing ligand-opioid receptor complex and in activating signal transduction
    Luca Gentilucci
    Dipartimento di Chimica G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Curr Drug Targets 8:185-96. 2007
  4. ncbi Peptides and peptidomimetics in medicine, surgery and biotechnology
    Luca Gentilucci
    Dept of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126, Bologna, Italy
    Curr Med Chem 13:2449-66. 2006
  5. ncbi A novel family of minimal PMRI cyclic peptides as versatile scaffolds for generating new molecular topology
    Luca Gentilucci
    Department of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Med Chem 2:395-400. 2006
  6. ncbi Investigation of the interaction between the atypical agonist c[YpwFG] and MOR
    Luca Gentilucci
    Dipartimento di Chimica G Ciamician, Universita degli Studi di Bologna, Italy
    FEBS J 275:2315-37. 2008
  7. ncbi Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics
    Luca Gentilucci
    Department of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    J Med Chem 53:106-18. 2010
  8. ncbi Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization
    Luca Gentilucci
    Department of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Curr Pharm Des 16:3185-203. 2010
  9. ncbi The inverse type?II ?-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists
    Luca Gentilucci
    Department of Chemistry G Ciamician, University of Bologna, Via Selmi 2, 40126 Bologna, Italy
    ChemMedChem 6:1640-53. 2011
  10. ncbi Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists
    Luca Gentilucci
    Dipartimento di Chimica G Ciamician, Via Selmi 2, Universita degli Studi di Bologna, 40126 Bologna, Italy
    Protein Pept Lett 14:51-6. 2007

Collaborators

Detail Information

Publications28

  1. ncbi Cyclopeptide analogs for generating new molecular and 3D diversity
    Luca Gentilucci
    Department of Chemistry G Ciamician, University of Bologna, 40126 Bologna, Italy
    Comb Chem High Throughput Screen 12:929-39. 2009
    ..Finally, we discuss the conformational features of such molecules as turn mimics. The comparison suggests that the retro-inverso modification allows a higher degree of three-dimensional diversity than normal peptides...
  2. ncbi Molecular docking of opiates and opioid peptides, a tool for the design of selective agonists and antagonists, and for the investigation of atypical ligand-receptor interactions
    L Gentilucci
    Department of Chemistry G Ciamician, University of Bologna, Via Selmi 2, 40126, Bologna, Italy
    Curr Med Chem 19:1587-601. 2012
    ..For the atypical structure of these compounds, the docking proved to be essential to disclose how they interact with and activate the receptors...
  3. ncbi Re-discussion of the importance of ionic interactions in stabilizing ligand-opioid receptor complex and in activating signal transduction
    Luca Gentilucci
    Dipartimento di Chimica G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Curr Drug Targets 8:185-96. 2007
    ..In particular, they strengthen the evidence that ORs can bind ligands via diverse binding modes, and in some cases an electrostatic interaction is not an absolute requirement...
  4. ncbi Peptides and peptidomimetics in medicine, surgery and biotechnology
    Luca Gentilucci
    Dept of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126, Bologna, Italy
    Curr Med Chem 13:2449-66. 2006
    ..Finally, peptide-based biomaterials can find applications in bio-nanotechnology for bio-microchips, peptide nanorods and nanotubes, bio-sensors, bio-electronic devices, and peptide-metal wires...
  5. ncbi A novel family of minimal PMRI cyclic peptides as versatile scaffolds for generating new molecular topology
    Luca Gentilucci
    Department of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Med Chem 2:395-400. 2006
    ..These scaffolds have been designed to permit easy introduction in a combinatorial fashion of a range of pharmacophores that possess a diversity of structure, function, and 3D disposition...
  6. ncbi Investigation of the interaction between the atypical agonist c[YpwFG] and MOR
    Luca Gentilucci
    Dipartimento di Chimica G Ciamician, Universita degli Studi di Bologna, Italy
    FEBS J 275:2315-37. 2008
    ....
  7. ncbi Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics
    Luca Gentilucci
    Department of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    J Med Chem 53:106-18. 2010
    ....
  8. ncbi Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization
    Luca Gentilucci
    Department of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Curr Pharm Des 16:3185-203. 2010
    ..This review focuses on modified peptides in which the peptide character is still preponderant, with particular emphasis on the chemical methodologies utilized to introduce the modifications...
  9. ncbi The inverse type?II ?-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists
    Luca Gentilucci
    Department of Chemistry G Ciamician, University of Bologna, Via Selmi 2, 40126 Bologna, Italy
    ChemMedChem 6:1640-53. 2011
    ....
  10. ncbi Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists
    Luca Gentilucci
    Dipartimento di Chimica G Ciamician, Via Selmi 2, Universita degli Studi di Bologna, 40126 Bologna, Italy
    Protein Pept Lett 14:51-6. 2007
    ....
  11. ncbi Development of isoxazoline-containing peptidomimetics as dual ?v?3 and ?5?1 integrin ligands
    Alessandra Tolomelli
    Department of Chemistry G Ciamician, University of Bologna, Via Selmi 2, 40126 Bologna, Italy
    ChemMedChem 6:2264-72. 2011
    ..The molecular basis of the observed inhibitory activity was suggested on the results of docking experiments...
  12. ncbi Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds
    Fides Benfatti
    Dipartimento di Chimica G Ciamician, Universita di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Bioorg Med Chem 15:7380-90. 2007
    ..The synthesis and the antiadhesion activity of a small library of peptidomimetics capable to recognize alpha(v)beta(3) and alpha(5)beta(1) integrins has been herein reported...
  13. ncbi Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics
    Luca Gentilucci
    Department of Chemistry G Ciamician, Universita degli Studi di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Bioorg Med Chem Lett 17:2329-33. 2007
    ..In particular, peptides 4 and 8 showed an IC(50) in the 10(-8)M range. Despite the linear structure, the peptides tend to adopt a folded conformation in a polar environment...
  14. ncbi Stability against enzymatic hydrolysis of endomorphin-1 analogues containing beta-proline
    Giuliana Cardillo
    Dipartimento di Chimica G Ciamician, Universita di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Org Biomol Chem 1:1498-502. 2003
    ..The presence of beta-proline alone is sufficient to confer good resistance against the hydrolysis of the biologically strategic Pro-Trp bond...
  15. ncbi Synthesis and conformational analysis of cyclotetrapeptide mimetic beta-turn templates and validation as 3D scaffolds
    Luca Gentilucci
    Department of Chemistry G Ciamician, University of Bologna, Italy
    ChemMedChem 4:517-23. 2009
    ..The peptide mimetics can be regarded as 3D scaffolds for designing molecules with a predictable display of the pharmacophores. We used the models for testing novel RGD analogues as alpha(v)beta(3)-integrin receptor antagonists...
  16. ncbi Synthesis and evaluation of the affinity toward mu-opioid receptors of atypical, lipophilic ligands based on the sequence c[-Tyr-Pro-Trp-Phe-Gly-]
    Giuliana Cardillo
    Dipartimento di Chimica G Ciamician and CSFM, Via Selmi 2, Universita di Bologna, 40126 Bologna, Italy
    J Med Chem 47:5198-203. 2004
    ....
  17. ncbi Conformational analysis and mu-opioid receptor affinity of short peptides, endomorphin models in a low polarity solvent
    Giuliana Cardillo
    Dipartimento di Chimica G Ciamician, C S F M, Universita di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Org Biomol Chem 1:3010-4. 2003
    ..To test the reliability of the peptides as endomorphin conformational models, we measured the affinities for mu-receptors labelled with [3H]-DAMGO. In particular, Cbz-Pro-Trp-PheNH2 displayed a nanomolar affinity...
  18. ncbi Synthesis and biological evaluation of unprecedented classes of spiro-beta-lactams and azido-beta-lactams as acyl-CoA:cholesterol acyltransferase inhibitors
    Fides Benfatti
    Dipartimento di Chimica G Ciamician, Universita di Bologna, Via Selmi 2, 40126 Bologna, Italy
    Bioorg Med Chem Lett 17:1946-50. 2007
    ..The potential of these particular beta-lactams as biologically active compounds has been confirmed by the results obtained in ACAT inhibition assays...
  19. ncbi A straightforward route to enantiopure 2-substituted-3,4-dehydro-?-proline via ring closing metathesis
    Alessandra Tolomelli
    Department of Chemistry, G Ciamician, University of Bologna, Via Selmi 2, 40126, Bologna, Italy
    Amino Acids 41:575-86. 2011
    ..Moreover, in view of a future application of these dehydro-?-amino acids as central core of peptidomimetics, the malonate chain was also used to protect nitrogen prior to RCM...
  20. ncbi Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model
    Andrea Bedini
    Department of Pharmacology, University of Bologna, Irnerio 48, 4126 Bologna, Italy
    Peptides 31:2135-40. 2010
    ..In conclusion, c[YpwFG] displays sufficient metabolic stability to be effective after peripheral administration and demonstrates the therapeutic potential of endomorphin derivatives as novel analgesic agents to control visceral pain...
  21. ncbi New trends in the development of opioid peptide analogues as advanced remedies for pain relief
    Luca Gentilucci
    Dipartimento di Chimica G Ciamician, Via Selmi 2, Universita degli Studi di Bologna, 40126 Bologna, Italy
    Curr Top Med Chem 4:19-38. 2004
    ....
  22. ncbi Recent advances in the investigation of the bioactive conformation of peptides active at the micro-opioid receptor. conformational analysis of endomorphins
    Luca Gentilucci
    Dipartimento di Chimica G Ciamician, Via Selmi 2, Universita degli Studi di Bologna, 40126 Bologna, Italy
    Curr Top Med Chem 4:105-21. 2004
    ....
  23. ncbi Synthesis of dehydro-beta-amino esters via highly regioselective amination of allylic carbonates
    Fides Benfatti
    Department of Chemistry G Ciamician, University of Bologna, Bologna, Italy
    Org Lett 10:2425-8. 2008
    ....
  24. ncbi Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline
    Santi Spampinato
    Department of Pharmacology, University of Bologna, Irnerio 48, 40126 Bologna, Italy
    Eur J Pharmacol 469:89-95. 2003
    ..This compound will be extremely useful for exploring the pharmacological profile of endomorphins in vivo and confirms the potential therapeutic interest of endomorphin derivatives as novel analgesic agents...
  25. ncbi Synthesis and biological evaluation of azido- and aziridino-hydroxyl-beta-lactams through stereo- and regioselective epoxide ring opening
    Fides Benfatti
    Department of Chemistry G. Ciamician, University of Bologna, Via Selmi 2, 40126 Bologna, Italy
    J Org Chem 71:9229-32. 2006
    ..The straightforwardness of the procedure makes this strategy useful for the synthesis of potentially bioactive compounds. Some selected examples showed promising activity in acyl CoA-cholesterol acyltransferase inhibition assays...
  26. ncbi Highly diastereoselective allylic azide formation and isomerization. Synthesis of 3(2'-amino)-beta-lactams
    Giuliana Cardillo
    Department of Chemistry G Ciamician, University of Bologna, Via Selmi 2, 40126 Bologna, Italy
    Org Lett 7:533-6. 2005
    ..reaction: see text]..
  27. ncbi Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance
    Giuliana Cardillo
    Dipartimento di Chimica G. Ciamician, Via Selmi 2, , 40126-Bologna, Italy
    J Med Chem 45:2571-8. 2002
    ..These features suggest that this novel class of endomorphin-1 analogues may represent suitable candidates for the in vivo investigation as potential mu-opioid receptor agonists...
  28. ncbi Expedient synthesis of pseudo-Pro-containing peptides: towards constrained peptidomimetics and foldamers
    Rossella De Marco
    Department of Chemistry G Ciamician, University of Bologna, Via Selmi 2, 40126 Bologna, Italy
    Org Biomol Chem 10:2307-17. 2012
    ....